Senior Manager, Nonclinical Development

David Allen, Ph.D.

David joined atai Life Sciences in the spring of 2022. Previously, Dr. Allen was a Program Manager and Clinical Pharmacology Specialist at Nuventra Pharma Services where he worked on several Investigational New Drug applications, Investigator Brochures, Clinical Study Reports, and GLP toxicokinetic reports.

Prior to that, he was a post-doc at the Children’s Hospital of Philadelphia where he worked on treatment options for patients with pediatric leukemia such as kinase inhibitors and CAR-T cell therapies.

Dr. Allen holds a BS in Neuroscience from the University of Minnesota, and a Ph.D. in Experimental and Clinical Pharmacology, also from the University of Minnesota.

<<  Back to our team